Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	nuclear retinoid X receptor binding	NCOA2 NCOR2 NCOA6 RARG	2.00e-06	23	80	4	GO:0046965
GeneOntologyMolecularFunction	transcription factor binding	NCOA2 NCOR2 NCOA6 TAF3 RARG ESRRB KMT2A TACC2 BSN KLF4 PRDM16 MEF2A	4.34e-05	753	80	12	GO:0008134
GeneOntologyMolecularFunction	nuclear glucocorticoid receptor binding	NCOA2 NCOR2 NCOA6	6.72e-05	20	80	3	GO:0035259
GeneOntologyMolecularFunction	nuclear retinoic acid receptor binding	NCOA2 NCOR2 NCOA6 RARG	6.97e-05	55	80	4	GO:0042974
GeneOntologyMolecularFunction	DNA-binding transcription factor binding	NCOA2 NCOR2 NCOA6 RARG ESRRB KMT2A TACC2 KLF4 PRDM16 MEF2A	1.08e-04	582	80	10	GO:0140297
GeneOntologyMolecularFunction	RNA polymerase II-specific DNA-binding transcription factor binding	NCOA2 NCOR2 NCOA6 RARG ESRRB TACC2 KLF4 MEF2A	2.64e-04	417	80	8	GO:0061629
GeneOntologyMolecularFunction	glycerol channel activity	AQP7B AQP7P3	3.29e-04	7	80	2	GO:0015254
GeneOntologyMolecularFunction	urea transmembrane transporter activity	AQP7B AQP7P3	5.60e-04	9	80	2	GO:0015204
GeneOntologyMolecularFunction	glycerol transmembrane transporter activity	AQP7B AQP7P3	5.60e-04	9	80	2	GO:0015168
GeneOntologyMolecularFunction	chromatin binding	NCOA2 NCOR2 NCOA6 RARG GLI3 KMT2A ANKRD17 NCAPH2 KLF4 MEF2A	7.20e-04	739	80	10	GO:0003682
GeneOntologyMolecularFunction	histone H3 methyltransferase activity	SETBP1 KMT2A PRDM16	7.29e-04	44	80	3	GO:0140938
GeneOntologyMolecularFunction	nuclear receptor binding	NCOA2 NCOR2 NCOA6 RARG TACC2	9.30e-04	187	80	5	GO:0016922
GeneOntologyMolecularFunction	polyol transmembrane transporter activity	AQP7B AQP7P3	1.20e-03	13	80	2	GO:0015166
GeneOntologyMolecularFunction	beta-catenin binding	GLI3 SPECC1L KLF4 CDH13	1.38e-03	120	80	4	GO:0008013
GeneOntologyMolecularFunction	water channel activity	AQP7B AQP7P3	2.07e-03	17	80	2	GO:0015250
GeneOntologyMolecularFunction	protein-lysine N-methyltransferase activity	SETBP1 KMT2A PRDM16	2.57e-03	68	80	3	GO:0016279
GeneOntologyMolecularFunction	lysine N-methyltransferase activity	SETBP1 KMT2A PRDM16	2.68e-03	69	80	3	GO:0016278
GeneOntologyMolecularFunction	histone H3K4 methyltransferase activity	SETBP1 KMT2A	2.87e-03	20	80	2	GO:0042800
GeneOntologyMolecularFunction	water transmembrane transporter activity	AQP7B AQP7P3	2.87e-03	20	80	2	GO:0005372
GeneOntologyMolecularFunction	histone deacetylase binding	NCOR2 GLI3 KLF4 MEF2A	2.89e-03	147	80	4	GO:0042826
GeneOntologyMolecularFunction	histone methyltransferase activity	SETBP1 KMT2A PRDM16	2.91e-03	71	80	3	GO:0042054
GeneOntologyMolecularFunction	proline-rich region binding	ABI2 ITSN1	3.17e-03	21	80	2	GO:0070064
GeneOntologyMolecularFunction	semaphorin receptor binding	SEMA6D SEMA6A	3.80e-03	23	80	2	GO:0030215
Domain	AT_hook	SETBP1 KMT2A	1.89e-03	16	76	2	PF02178
Domain	CH	CFAP47 NAV2 SPECC1L	2.91e-03	70	76	3	PF00307
Domain	Semaphorin	SEMA6D SEMA6A	2.96e-03	20	76	2	IPR027231
Domain	-	CFAP47 NAV2 SPECC1L	3.03e-03	71	76	3	1.10.418.10
Domain	CH	CFAP47 NAV2 SPECC1L	3.28e-03	73	76	3	PS50021
Domain	CH-domain	CFAP47 NAV2 SPECC1L	3.54e-03	75	76	3	IPR001715
Domain	AT_hook	SETBP1 KMT2A	5.37e-03	27	76	2	SM00384
Domain	AT_hook_DNA-bd_motif	SETBP1 KMT2A	5.37e-03	27	76	2	IPR017956
Domain	Sema	SEMA6D SEMA6A	7.04e-03	31	76	2	SM00630
Domain	Semap_dom	SEMA6D SEMA6A	7.04e-03	31	76	2	IPR001627
Domain	Sema	SEMA6D SEMA6A	7.04e-03	31	76	2	PF01403
Domain	SEMA	SEMA6D SEMA6A	7.04e-03	31	76	2	PS51004
Domain	PSI	SEMA6D SEMA6A	7.49e-03	32	76	2	PF01437
Domain	Plexin_repeat	SEMA6D SEMA6A	7.49e-03	32	76	2	IPR002165
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	HIVEP3 NCOR2 FAM193B NCOA6 SH3PXD2B LMAN2L RARG PTPRF SIPA1L3 GTSE1 MAML1 NAV2 APEH KLF4 PRDM16 C2CD2L	4.68e-09	1105	81	16	35748872
Pubmed	Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.	CEP170 NCOA2 NCOR2 SH3PXD2B ATXN2 ABI2 NETO1 ITSN1 SIPA1L3 PAK1 ANKRD17 SPECC1L BSN GABBR2 NOSIP	5.74e-09	963	81	15	28671696
Pubmed	Proteome-scale mapping of binding sites in the unstructured regions of the human proteome.	NCOR2 NCOA6 ATXN2 ITSN1 PIK3R3 SETBP1 GTSE1 PAK1 BSN SAP130	6.46e-08	430	81	10	35044719
Pubmed	Fezl regulates the differentiation and axon targeting of layer 5 subcortical projection neurons in cerebral cortex.	NEO1 SEMA6D NETO1 GLI3 SEMA6A CDH13	5.21e-07	126	81	6	16284245
Pubmed	A genome-wide screen to identify transcription factors expressed in pelvic Ganglia of the lower urinary tract.	NCOA2 RARG SPOPL GLI3 ESRRB KMT2A TACC2 FOXN3 KLF4 PRDM16 MEF2A	7.77e-07	709	81	11	22988430
Pubmed	Human transcription factor protein interaction networks.	NCOA2 NCOR2 NCOA6 TAF3 MRS2 ATXN2 GLI3 MAML1 KMT2A ANKRD17 KLF4 PRDM16 SAP130 MEF2A NOSIP	9.48e-07	1429	81	15	35140242
Pubmed	Identification of proximal SUMO-dependent interactors using SUMO-ID.	CEP170 NCOA2 SMAP1 NCOR2 GTSE1 MAMLD1 PAK1 TACC2 NOSIP	9.62e-07	444	81	9	34795231
Pubmed	Construction of expression-ready cDNA clones for KIAA genes: manual curation of 330 KIAA cDNA clones.	NCOA6 SIPA1L3 SETBP1 NAV2 PRDM16 UNC80 C2CD2L	1.00e-06	225	81	7	12168954
Pubmed	Comparative Application of BioID and TurboID for Protein-Proximity Biotinylation.	NCOA2 NCOR2 NCOA6 ATXN2 MAMLD1 MAML1 ANKRD17 SAP130 NUP35	1.22e-06	457	81	9	32344865
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	CEP170 NCOA2 HIVEP3 NCOR2 ATXN2 NETO1 SIPA1L3 PIK3R3 SETBP1 ANKRD17 SEMA6A LTBR FOXN3 SAP130 MEF2A	1.58e-06	1489	81	15	28611215
Pubmed	Systematic bromodomain protein screens identify homologous recombination and R-loop suppression pathways involved in genome integrity.	CEP170 NCOR2 TAF3 GLI3 PIK3R3 RTL9 ANKRD17 SREK1 SQOR PRDM16 SAP130 UNC80 C2CD2L	1.77e-06	1116	81	13	31753913
Pubmed	Proximity-dependent Mapping of the Androgen Receptor Identifies Kruppel-like Factor 4 as a Functional Partner.	NCOA2 NCOA6 MAML1 KMT2A KLF4 SAP130 MEF2A	3.19e-06	268	81	7	33640491
Pubmed	A Role for KLF4 in Promoting the Metabolic Shift via TCL1 during Induced Pluripotent Stem Cell Generation.	TCL1A KLF4	5.36e-06	2	81	2	28262547
Pubmed	Abl-interactor 2 (ABI2): a novel MLL translocation partner in acute myeloid leukemia.	ABI2 KMT2A	5.36e-06	2	81	2	22304832
Pubmed	The RNA-mediated estrogen receptor α interactome of hormone-dependent human breast cancer cell nuclei.	GORASP2 LMAN2L ATXN2 ABI2 SIPA1L3 MAML1 KMT2A ANKRD17 SREK1 SPECC1L KLF4 SQOR NUP35 C2CD2L	8.61e-06	1497	81	14	31527615
Pubmed	The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers.	CEP170 NCOR2 NCOA6 TAF3 ATXN2 GTSE1 KMT2A SREK1 SAP130 SF3B2 NOSIP	1.31e-05	954	81	11	36373674
Pubmed	T0070907, a selective ligand for peroxisome proliferator-activated receptor gamma, functions as an antagonist of biochemical and cellular activities.	NCOA2 NCOR2 NCOA6	1.35e-05	20	81	3	11877444
Pubmed	Nuclear receptor-coregulator interaction profiling identifies TRIP3 as a novel peroxisome proliferator-activated receptor gamma cofactor.	NCOA2 NCOR2 NCOA6	1.57e-05	21	81	3	19596656
Pubmed	Shear stress-regulated miR-27b controls pericyte recruitment by repressing SEMA6A and SEMA6D.	SEMA6D SEMA6A	1.60e-05	3	81	2	28453731
Pubmed	Aberrant alternative splicing of thyroid hormone receptor in a TSH-secreting pituitary tumor is a mechanism for hormone resistance.	NCOA2 NCOR2	1.60e-05	3	81	2	11518802
Pubmed	Retinoic acid receptors beta and gamma do not repress, but instead activate target gene transcription in both the absence and presence of hormone ligand.	NCOR2 RARG	1.60e-05	3	81	2	12554770
Pubmed	Correction of X-linked chronic granulomatous disease by gene therapy, augmented by insertional activation of MDS1-EVI1, PRDM16 or SETBP1.	SETBP1 PRDM16	1.60e-05	3	81	2	16582916
Pubmed	Interaction network of human early embryonic transcription factors.	NCOA2 NCOR2 NCOA6 TAF3 MAML1 KMT2A PRDM16	1.84e-05	351	81	7	38297188
Pubmed	Retinoic acid signalling induces the differentiation of mouse fetal liver-derived hepatic progenitor cells.	NCOA2 NCOR2 RARG	2.08e-05	23	81	3	19737349
Pubmed	Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes.	NCOA2 NCOR2 ABI2 GTSE1 MAML1 ANKRD17 FOXN3 SAP130 MEF2A SF3B2	3.03e-05	857	81	10	25609649
Pubmed	Constitutive activation of transcription and binding of coactivator by estrogen-related receptors 1 and 2.	NCOA2 ESRRB	3.20e-05	4	81	2	10598588
Pubmed	Genome-wide association study identifies three novel genetic markers associated with elite endurance performance.	ESRRB CDH13	3.20e-05	4	81	2	25729143
Pubmed	SRCAP complex promotes lung cancer progression by reprograming the oncogenic transcription of Hippo-YAP/TAZ signaling pathway.	CEP170 NCOA2 NCOA6 SH3PXD2B TAF3 KMT2A SPECC1L SAP130	4.29e-05	549	81	8	38280479
Pubmed	Identification of the SOX2 Interactome by BioID Reveals EP300 as a Mediator of SOX2-dependent Squamous Differentiation and Lung Squamous Cell Carcinoma Growth.	NCOA2 NCOR2 NCOA6 SAP130	4.36e-05	83	81	4	28794006
Pubmed	PRISMA and BioID disclose a motifs-based interactome of the intrinsically disordered transcription factor C/EBPα.	CEP170 NCOA2 NCOR2 NCOA6 ATXN2 MAML1 APEH KMT2A SAP130 MEF2A NOSIP	4.95e-05	1103	81	11	34189442
Pubmed	Functional analysis of secreted and transmembrane proteins critical to mouse development.	NEO1 PTPRF SEMA6A	5.22e-05	31	81	3	11431694
Pubmed	Antiandrogen effects of mifepristone on coactivator and corepressor interactions with the androgen receptor.	NCOA2 NCOR2	5.33e-05	5	81	2	14593076
Pubmed	Interleukin-1 receptor accessory protein organizes neuronal synaptogenesis as a cell adhesion molecule.	PTPRF BSN	5.33e-05	5	81	2	22357843
Pubmed	The opposing transcriptional activities of the two isoforms of the human progesterone receptor are due to differential cofactor binding.	NCOA2 NCOR2	5.33e-05	5	81	2	10757795
Pubmed	Coactivator and corepressor gene expression in rat cerebellum during postnatal development and the effect of altered thyroid status.	NCOA2 NCOR2	5.33e-05	5	81	2	10803578
Pubmed	Identification and developmental analysis of genes expressed by dopaminergic neurons of the substantia nigra pars compacta.	HIVEP3 PTPRF KMT2A SREK1	5.99e-05	90	81	4	15033168
Pubmed	A dual-strategy expression screen for candidate connectivity labels in the developing thalamus.	SEMA6D NETO1 SEMA6A CDH13	6.25e-05	91	81	4	28558017
Pubmed	Large-scale characterization of HeLa cell nuclear phosphoproteins.	NCOR2 NCOA6 TAF3 ITSN1 GTSE1 KMT2A ANKRD17 PRG4 SF3B2	7.99e-05	774	81	9	15302935
Pubmed	Novel genetic variants modify the effect of smoking on carotid plaque burden in Hispanics.	SEMA6D SQOR	7.99e-05	6	81	2	24954085
Pubmed	CRM1 mediates nuclear export of HDAC7 independently of HDAC7 phosphorylation and association with 14-3-3s.	NCOR2 MEF2A	7.99e-05	6	81	2	16956611
Pubmed	Recruitment of MLL1 complex is essential for SETBP1 to induce myeloid transformation.	SETBP1 KMT2A	7.99e-05	6	81	2	35036869
Pubmed	Isotype-restricted corepressor recruitment: a constitutively closed helix 12 conformation in retinoic acid receptors beta and gamma interferes with corepressor recruitment and prevents transcriptional repression.	NCOR2 RARG	1.12e-04	7	81	2	12665583
Pubmed	Interaction between GRIP and liprin-alpha/SYD2 is required for AMPA receptor targeting.	NCOA2 PTPRF	1.12e-04	7	81	2	11931740
Pubmed	Cracking the egg: molecular dynamics and evolutionary aspects of the transition from the fully grown oocyte to embryo.	CFAP47 TCL1A NAV2 DMAC1 NUP35 NOSIP	1.16e-04	326	81	6	17015433
Pubmed	A novel role for the peptidyl-prolyl cis-trans isomerase Cyclophilin A in DNA-repair following replication fork stalling via the MRE11-RAD50-NBS1 complex.	CEP170 SMAP1 NCOA6 SH3PXD2B ITSN1 GTSE1 SAP130	1.19e-04	472	81	7	38943005
Pubmed	TNF-α inhibits glucocorticoid receptor-induced gene expression by reshaping the GR nuclear cofactor profile.	NCOA2 NCOR2 NCOA6 MAML1 MUC16 ANKRD17 BSN NOSIP	1.22e-04	638	81	8	31182584
Pubmed	Maternal genes and facial clefts in offspring: a comprehensive search for genetic associations in two population-based cleft studies from Scandinavia.	RARG GLI3 ESRRB FOXN3 GABBR2 PRDM16	1.27e-04	331	81	6	20634891
Pubmed	Voltage-dependent conformational changes of Kv1.3 channels activate cell proliferation.	NCOA2 KMT2A ANKRD17 SPECC1L BSN	1.29e-04	208	81	5	33230847
Pubmed	Large-scale phosphomimetic screening identifies phospho-modulated motif-based protein interactions.	NCOR2 ITSN1 GTSE1 MEF2A	1.31e-04	110	81	4	37219487
Pubmed	Dissecting self-renewal in stem cells with RNA interference.	TCL1A ESRRB	1.49e-04	8	81	2	16767105
Pubmed	Identification of the antibiotic ionomycin as an unexpected peroxisome proliferator-activated receptor γ (PPARγ) ligand with a unique binding mode and effective glucose-lowering activity in a mouse model of diabetes.	NCOA2 NCOR2	1.49e-04	8	81	2	23178929
Pubmed	Lrig2 Negatively Regulates Ectodomain Shedding of Axon Guidance Receptors by ADAM Proteases.	NEO1 SEMA6A	1.49e-04	8	81	2	26651291
Pubmed	OCT4 induces embryonic pluripotency via STAT3 signaling and metabolic mechanisms.	ESRRB KLF4	1.49e-04	8	81	2	33452132
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	CEP170 USP31 NCOA6 SH3PXD2B SIPA1L3 GTSE1 NAV2 KMT2A ANKRD17	1.78e-04	861	81	9	36931259
Pubmed	The TFIID components human TAF(II)140 and Drosophila BIP2 (TAF(II)155) are novel metazoan homologues of yeast TAF(II)47 containing a histone fold and a PHD finger.	TAF3 SAP130	1.91e-04	9	81	2	11438666
Pubmed	Physical Interactions and Functional Coordination between the Core Subunits of Set1/Mll Complexes and the Reprogramming Factors.	KMT2A KLF4	1.91e-04	9	81	2	26691508
Pubmed	Neogenin regulates Sonic Hedgehog pathway activity during digit patterning.	NEO1 GLI3	2.38e-04	10	81	2	22275192
Pubmed	The core component of the mammalian SWI/SNF complex SMARCD3/BAF60c is a coactivator for the nuclear retinoic acid receptor.	NCOA2 RARG	2.38e-04	10	81	2	17363140
Pubmed	Transcriptional cofactors exhibit differential preference toward peroxisome proliferator-activated receptors alpha and delta in uterine cells.	NCOA2 NCOR2	2.38e-04	10	81	2	15001550
Pubmed	Distinct Roles of Transcription Factors KLF4, Krox20, and Peroxisome Proliferator-Activated Receptor γ in Adipogenesis.	KLF4 PRDM16	2.38e-04	10	81	2	27777310
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: III. the complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	FMNL3 NCOA6 SETBP1 MAML1 NAV2 ANKRD17 BSN	2.38e-04	529	81	7	14621295
Pubmed	A census of human transcription factors: function, expression and evolution.	HIVEP3 RARG GLI3 ESRRB SETBP1 KMT2A FOXN3 KLF4 MEF2A	2.63e-04	908	81	9	19274049
Pubmed	In vitro capture and characterization of embryonic rosette-stage pluripotency between naive and primed states.	ESRRB KLF4	2.91e-04	11	81	2	32367046
Pubmed	The Hippocampal Response to Acute Corticosterone Elevation Is Altered in a Mouse Model for Angelman Syndrome.	NCOA2 NCOA6	2.91e-04	11	81	2	36613751
Pubmed	HDAC3 ensures stepwise epidermal stratification via NCoR/SMRT-reliant mechanisms independent of its histone deacetylase activity.	NCOR2 KLF4	2.91e-04	11	81	2	32467224
Pubmed	A genome-wide study of common SNPs and CNVs in cognitive performance in the CANTAB.	NCOR2 GORASP2 TENT4A	3.42e-04	58	81	3	19734545
Pubmed	Spatiotemporal-resolved protein networks profiling with photoactivation dependent proximity labeling.	CEP170 NCOR2 ATXN2 APEH SAP130 SF3B2	3.45e-04	399	81	6	35987950
Pubmed	On and off retinal circuit assembly by divergent molecular mechanisms.	SEMA6D SEMA6A	3.48e-04	12	81	2	24179230
Pubmed	Two distinct nuclear receptor-interaction domains and CREB-binding protein-dependent transactivation function of activating signal cointegrator-2.	NCOR2 NCOA6	3.48e-04	12	81	2	11158331
Pubmed	Plexin-B1 directly interacts with PDZ-RhoGEF/LARG to regulate RhoA and growth cone morphology.	PAK1 KMT2A	3.48e-04	12	81	2	12123608
Pubmed	Spop regulates Gli3 activity and Shh signaling in dorsoventral patterning of the mouse spinal cord.	SPOPL GLI3	3.48e-04	12	81	2	28412462
Pubmed	A protein interaction network for Ecm29 links the 26 S proteasome to molecular motors and endosomal components.	ANKRD17 SPECC1L SF3B2	3.78e-04	60	81	3	20682791
Pubmed	RNF43 inhibits WNT5A-driven signaling and suppresses melanoma invasion and resistance to the targeted therapy.	GORASP2 ATXN2 GLI3 ITSN1 PDZD4	3.82e-04	263	81	5	34702444
Pubmed	Combined Overexpression of JARID2, PRDM14, ESRRB, and SALL4A Dramatically Improves Efficiency and Kinetics of Reprogramming to Induced Pluripotent Stem Cells.	ESRRB KLF4	4.11e-04	13	81	2	26523946
Pubmed	Fv2 encodes a truncated form of the Stk receptor tyrosine kinase.	APEH BSN	4.11e-04	13	81	2	10508511
Pubmed	Temporomandibular joint formation and condyle growth require Indian hedgehog signaling.	GLI3 PRG4	4.11e-04	13	81	2	17191253
Pubmed	Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability.	NCOA2 NCOR2 ITSN1 MAML1 TACC2 BSN NOSIP	4.50e-04	588	81	7	38580884
Pubmed	Defining the proximal interaction networks of Arf GTPases reveals a mechanism for the regulation of PLD1 and PI4KB.	SMAP1 GORASP2 NEO1 GLI3 MAML1 APEH MUC16 SPECC1L	4.58e-04	777	81	8	35844135
Pubmed	mTORC1 activity regulates post-translational modifications of glycine decarboxylase to modulate glycine metabolism and tumorigenesis.	CEP170 ATXN2 SIPA1L3 SPECC1L SF3B2	4.60e-04	274	81	5	34244482
Pubmed	Prediction of the coding sequences of unidentified human genes. XVI. The complete sequences of 150 new cDNA clones from brain which code for large proteins in vitro.	SH3PXD2B RTL9 NAV2 SEMA6A	4.60e-04	153	81	4	10718198
Pubmed	Deterministic and stochastic allele specific gene expression in single mouse blastomeres.	RARG GLI3 TCL1A ESRRB PIK3R3 KLF4	4.76e-04	424	81	6	21731673
Pubmed	Defining brain wiring patterns and mechanisms through gene trapping in mice.	NEO1 SEMA6A	4.79e-04	14	81	2	11242070
Pubmed	The contribution of rare and common variants in 30 genes to risk nicotine dependence.	GABBR2 CDH13	4.79e-04	14	81	2	25450229
Pubmed	Cyclin D-cdk4 activity modulates the subnuclear localization and interaction of MEF2 with SRC-family coactivators during skeletal muscle differentiation.	NCOA2 MEF2A	4.79e-04	14	81	2	12130539
Pubmed	Activating signal cointegrator 2 belongs to a novel steady-state complex that contains a subset of trithorax group proteins.	NCOA2 NCOA6	4.79e-04	14	81	2	12482968
Pubmed	Epiblast stem cell subpopulations represent mouse embryos of distinct pregastrulation stages.	ESRRB KLF4	4.79e-04	14	81	2	21056461
Pubmed	Genomic analysis of mouse retinal development.	NCOR2 CLIP3 GORASP2 ESRRB C16orf74 KMT2A TACC2 BSN MEF2A	5.54e-04	1006	81	9	15226823
Pubmed	Resolution of cell fate decisions revealed by single-cell gene expression analysis from zygote to blastocyst.	NCOA2 HIVEP3 GLI3 ESRRB KLF4 PRDM16 MEF2A SF3B2	5.92e-04	808	81	8	20412781
Pubmed	Identification of three novel genetic variations associated with electrocardiographic traits (QRS duration and PR interval) in East Asians.	SETBP1 PRDM16	6.29e-04	16	81	2	25035420
Pubmed	SET1 and p300 act synergistically, through coupled histone modifications, in transcriptional activation by p53.	NCOA6 KMT2A	6.29e-04	16	81	2	23870121
Pubmed	Optic chiasm presentation of Semaphorin6D in the context of Plexin-A1 and Nr-CAM promotes retinal axon midline crossing.	SEMA6D SEMA6A	6.29e-04	16	81	2	22632726
Pubmed	A genome-wide meta-analysis of genetic variants associated with allergic rhinitis and grass sensitization and their interaction with birth order.	GLI3 SEMA6A	6.29e-04	16	81	2	22036096
Pubmed	A protein interaction landscape of breast cancer.	CEP170 GORASP2 SIPA1L3 PIK3R3 NAV2 SPECC1L SQOR	7.01e-04	634	81	7	34591612
Pubmed	Association analysis of 3p21 with Crohn's disease in a New Zealand population.	APEH BSN	7.12e-04	17	81	2	20307617
Pubmed	Synovial joint formation requires local Ext1 expression and heparan sulfate production in developing mouse embryo limbs and spine.	GLI3 PRG4	7.12e-04	17	81	2	21185280
Pubmed	Screening and association testing of common coding variation in steroid hormone receptor co-activator and co-repressor genes in relation to breast cancer risk: the Multiethnic Cohort.	NCOA2 NCOR2	7.12e-04	17	81	2	19183483
Pubmed	Ankrd17, an ubiquitously expressed ankyrin factor, is essential for the vascular integrity during embryogenesis.	ANKRD17 KLF4	8.00e-04	18	81	2	19619540
Pubmed	Agonist-specific Protein Interactomes of Glucocorticoid and Androgen Receptor as Revealed by Proximity Mapping.	NCOA2 NCOR2 NCOA6	8.16e-04	78	81	3	28611094
Pubmed	Spop promotes skeletal development and homeostasis by positively regulating Ihh signaling.	SPOPL GLI3	8.93e-04	19	81	2	27930311
Pubmed	Cell-autonomous activation of Hedgehog signaling inhibits brown adipose tissue development.	GLI3 PRDM16	8.93e-04	19	81	2	25848030
Interaction	TOP3B interactions	HIVEP3 NCOR2 FAM193B NCOA6 SH3PXD2B GORASP2 LMAN2L RARG PTPRF ATXN2 SIPA1L3 GTSE1 MAML1 NAV2 APEH ANKRD17 KLF4 PRDM16 C2CD2L	3.50e-06	1470	80	19	int:TOP3B
Interaction	NUP35 interactions	NCOA2 HIVEP3 NCOR2 NCOA6 ATXN2 MAMLD1 MAML1 ANKRD17 SAP130 NUP35	6.77e-06	424	80	10	int:NUP35
Interaction	PAX9 interactions	NCOA2 NCOR2 NCOA6 MAML1 KLF4 SAP130	1.30e-05	130	80	6	int:PAX9
Interaction	PML interactions	CEP170 NCOA2 SMAP1 NCOR2 SAP25 PTPRF GTSE1 MAMLD1 PAK1 KMT2A TACC2 SQOR SAP130 NOSIP	1.64e-05	933	80	14	int:PML
Interaction	MAPRE3 interactions	CEP170 SH3PXD2B SIPA1L3 GTSE1 NAV2 TACC2 SPECC1L	3.60e-05	230	80	7	int:MAPRE3
Interaction	EGR2 interactions	NCOA2 NCOR2 NCOA6 MAML1 KMT2A PRDM16	6.11e-05	171	80	6	int:EGR2
GeneFamily	Immunoglobulin like domain containing\|Semaphorins	SEMA6D SEMA6A	1.07e-03	20	44	2	736
GeneFamily	Ataxins\|Trinucleotide repeat containing	NCOR2 ATXN2	1.68e-03	25	44	2	775
GeneFamily	Zinc fingers C2H2-type\|Lysine methyltransferases\|PR/SET domain family	KMT2A PRDM16	3.09e-03	34	44	2	487
GeneFamily	PDZ domain containing	GORASP2 SIPA1L3 PDZD4	6.00e-03	152	44	3	1220
GeneFamily	Nuclear hormone receptors	RARG ESRRB	6.33e-03	49	44	2	71
GeneFamily	Zinc fingers C2H2-type\|ZF class homeoboxes and pseudogenes	ZNF597 HIVEP3 GLI3 ZNF747 KLF4 PRDM16	7.49e-03	718	44	6	28
ToppCell	wk_15-18-Mesenchymal-Chondrocyte-intermediate_chondrocyte\|wk_15-18 / Celltypes from embryonic and fetal-stage human lung	COL8A2 RARG SETBP1 RTL9 SEMA6A PRDM16	8.10e-07	175	81	6	a84965d28438a4228d841b357c2cd75cf4b59a63
ToppCell	Control-Lymphoid-B\|World / Disease state, Lineage and Cell class	MS4A1 NETO1 TCL1A SIPA1L3 SETBP1 C16orf74	9.86e-07	181	81	6	9124f1a610cfc3355ad87921cd3eb5346956475d
ToppCell	nucseq-Immune-Lymphocytic_B-Lymphocytic_B-B\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	MS4A1 NETO1 TCL1A SIPA1L3 SETBP1 C16orf74	9.86e-07	181	81	6	8d8cc4dae2c8bd5f4b1c159f2a52edc4c9449c86
ToppCell	Control-Lymphoid-B\|Control / Disease state, Lineage and Cell class	MS4A1 NETO1 TCL1A SIPA1L3 SETBP1 C16orf74	1.08e-06	184	81	6	de0294f879268bfd68e91adcc2adba211d221b7a
ToppCell	10x5'-GI_large-bowel-Lymphocytic_B-Naive_B_cells\|GI_large-bowel / Manually curated celltypes from each tissue	MS4A1 NETO1 TCL1A SIPA1L3 C16orf74 KLF4	1.12e-06	185	81	6	1c99373c123b5e0de40b47d9d885974a747b9839
ToppCell	Control-Lymphoid-B\|Lymphoid / Disease state, Lineage and Cell class	MS4A1 TCL1A SIPA1L3 SETBP1 C16orf74 MEF2A	1.19e-06	187	81	6	4e64be635f445276e71f2937f33f041c3a4204ab
ToppCell	PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Lymphocytic-Lymphocytic_B-B_cell-B_c01-TCL1A\|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k)	MS4A1 NETO1 TCL1A SIPA1L3 SETBP1 C16orf74	1.19e-06	187	81	6	d01926be1c8846a25fb6706e26b56b808b69f8f0
ToppCell	IPF-Lymphoid-B\|Lymphoid / Disease state, Lineage and Cell class	MS4A1 TCL1A SIPA1L3 SETBP1 C16orf74 MEF2A	1.19e-06	187	81	6	af1327559f7e01bec070881cae52834917c3da65
ToppCell	renal_medulla_nuclei\|World / Celltypes from Cells and Nuclei per compartment and clinical group	NCOA2 SEMA6D ESRRB SETBP1 ANKRD17 PRDM16	1.27e-06	189	81	6	830d9cd0dd706bce22eb2416f07b2c31c870a05a
ToppCell	facs-Skin\|facs / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL8A2 RARG PTPRF TACC2 KLF4 CDH13	1.35e-06	191	81	6	ae524103331fa53fa82888dbb567fc36abcee7e0
ToppCell	Primary_Motor_Cortex_(M1)-Neuronal\|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	KIAA1549L NETO1 SETBP1 PAK1 GABBR2 UNC80	1.66e-06	198	81	6	4ca5ff320905ab4ff60ed90a5522227c782142a6
ToppCell	PBMC-Severe-Lymphocyte-B-B_cell-B_naive-B_naive-9\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	MS4A1 NETO1 TCL1A SETBP1 C16orf74	8.05e-06	150	81	5	d9931507257c64ead4a53786e6822f51962c6015
ToppCell	PBMC-Control-Lymphocyte-B-B_cell-B_naive-B_naive-12\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	CEP170 MS4A1 MRS2 NETO1 TCL1A	9.74e-06	156	81	5	7ece590fd8f29382e349dd0e5e016d2926aeb518
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Cortical_Thick_Ascending_Limb_Cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	HIVEP3 TMPRSS9 SEMA6D ESRRB PRDM16	1.13e-05	161	81	5	4bb7bae54ba3bdf46b525c01f5ad3db8e49819cb
ToppCell	BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_B-B_cell-B_c01-TCL1A\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	MS4A1 NETO1 TCL1A SIPA1L3 SETBP1	1.52e-05	171	81	5	c3e3ea09c73050372314a89b282e36ba5f339d73
ToppCell	metastatic_Brain-Endothelial_cells-Stalk-like_ECs\|Endothelial_cells / Location, Cell class and cell subclass	LMAN2L MAMLD1 PRDM16 CDH13 PDZD4	1.70e-05	175	81	5	f6a6db992e803d36c866a91706b02f67e0fd3e09
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	OTOGL SETBP1 PRG4 PRDM16 CDH13	1.70e-05	175	81	5	316f2ea930437bf1243b1c0f45e6bd864112c6f2
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	OTOGL SETBP1 PRG4 PRDM16 CDH13	1.70e-05	175	81	5	a9f08e1e4c2997dcdd3e5d92daac480da19100b8
ToppCell	Control-B_cells-B_cells\|Control / group, cell type (main and fine annotations)	MS4A1 NETO1 TCL1A SETBP1 C16orf74	1.74e-05	176	81	5	d2c353783bd78dc24f28e00d917b88d8294fb5df
ToppCell	5'-Adult-LymphNode-Endothelial-blood_vessel_EC-arterial_capillary\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	FMNL3 NETO1 PIK3R3 MUC16 AQP7B	1.84e-05	178	81	5	360d7a987f91d6d721487a921824057ec31a7332
ToppCell	LPS-IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT1\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	PTPRF NAV2 TACC2 PRDM16 CDH13	1.89e-05	179	81	5	04ce3673e46606f63d9c87bcba3a64c96817d812
ToppCell	Children_(3_yrs)-Immune-B_cell-D139\|Children_(3_yrs) / Lineage, Cell type, age group and donor	MS4A1 NETO1 TCL1A SETBP1 C16orf74	1.94e-05	180	81	5	40a12eb852373ae3d7c8d9bca376b0ae99f724b3
ToppCell	IPF-Lymphoid-B\|World / Disease state, Lineage and Cell class	MS4A1 NETO1 TCL1A SETBP1 C16orf74	1.94e-05	180	81	5	30f9398c9b784f49470847a025bac90687e997a1
ToppCell	3'_v3-Lung-Lymphocytic_B\|Lung / Manually curated celltypes from each tissue	MS4A1 NETO1 TCL1A SETBP1 C16orf74	1.94e-05	180	81	5	237a2130a3f48595dad2417539c21e44585962b8
ToppCell	PBMC-Convalescent-Lymphocyte-B-B_cell-B_naive-B_naive-2\|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	MS4A1 TCL1A UCP3 ZNF747 SAP130	1.99e-05	181	81	5	75035a3211e524bb659b82e6979f7d3a3121ae70
ToppCell	10x5'-Lung-Lymphocytic_B\|Lung / Manually curated celltypes from each tissue	MS4A1 NETO1 TCL1A SETBP1 C16orf74	2.05e-05	182	81	5	310f94437d197eaaaf6e30e68063b33e94befe77
ToppCell	BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_B-B_cell\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	MS4A1 NETO1 TCL1A SIPA1L3 SETBP1	2.05e-05	182	81	5	ccd729388d997cc45071175cb0c3db6d0790eaf8
ToppCell	nucseq-Immune-Lymphocytic_B\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	MS4A1 TCL1A SIPA1L3 SETBP1 C16orf74	2.16e-05	184	81	5	911658e7bb499c1bbc8419eec8ff88729bc39a75
ToppCell	BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_B\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	MS4A1 NETO1 TCL1A SIPA1L3 SETBP1	2.16e-05	184	81	5	d18e94839a62fca536ae1630c154e5d0aafc44c5
ToppCell	nucseq-Immune-Lymphocytic_B-Lymphocytic_B\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	MS4A1 TCL1A SIPA1L3 SETBP1 C16orf74	2.16e-05	184	81	5	942b58ae7172bb5f97e55b032db9329d161854af
ToppCell	PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_Arw_fibro_(16)\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	COL8A2 SEMA6D ESRRB NAV2 UNC80	2.21e-05	185	81	5	7dcdc009c5681ee05dd18968f7e85c3403fe34af
ToppCell	COPD-Lymphoid-B\|COPD / Disease state, Lineage and Cell class	MS4A1 TCL1A SIPA1L3 SETBP1 C16orf74	2.21e-05	185	81	5	925e79c35c381dd44ec5fb921dca09ce43140135
ToppCell	Fetal_29-31_weeks-Mesenchymal-airway_smooth_muscle_cell-D088\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	SEMA6D MAMLD1 NAV2 TACC2 SPOCD1	2.21e-05	185	81	5	e58a009aaf342be019a909747b1895d5987d4daf
ToppCell	Children_(3_yrs)-Immune-B_cell\|Children_(3_yrs) / Lineage, Cell type, age group and donor	MS4A1 NETO1 TCL1A SETBP1 C16orf74	2.27e-05	186	81	5	aa576748921a318798b911a611f05319b95e8d5e
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_B-B_cell-B_c01-TCL1A\|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k)	MS4A1 NETO1 TCL1A SIPA1L3 SETBP1	2.39e-05	188	81	5	d8decd9b5967873ca8320c2f9f07365f163c777f
ToppCell	PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_B-B_cell-B_c04-SOX5-TNFRSF1B\|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k)	MS4A1 NETO1 SIPA1L3 SETBP1 MEF2A	2.45e-05	189	81	5	2b53dae0e6e85b7139f8a9872fbebb3705b2f1bf
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_B-B_cell-B_c01-TCL1A\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	MS4A1 NETO1 TCL1A C16orf74 KLF4	2.52e-05	190	81	5	60bb6aaea9691d07295f61c14d1650f5041a0f9c
ToppCell	COPD-Lymphoid-B\|Lymphoid / Disease state, Lineage and Cell class	CEP170 MS4A1 SIPA1L3 SETBP1 MEF2A	2.52e-05	190	81	5	1e85ee686ff6dd27c69415d524d54fa825b1daad
ToppCell	PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Lymphocytic-Lymphocytic_B\|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k)	MS4A1 NETO1 TCL1A SETBP1 C16orf74	2.58e-05	191	81	5	a831e30f37aff329d83fac9bdb84f783075d5df6
ToppCell	Fetal_29-31_weeks-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	USP31 SEMA6A KLF4 MEF2A CDH13	2.58e-05	191	81	5	1de0bdfd13bd930691564c2673f2e66393bc0255
ToppCell	PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Lymphocytic-Lymphocytic_B-B_cell\|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k)	MS4A1 NETO1 TCL1A SETBP1 C16orf74	2.58e-05	191	81	5	2453064c39b359088d43d52792bf829f83442c82
ToppCell	PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_B\|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k)	MS4A1 NETO1 TCL1A SETBP1 C16orf74	2.71e-05	193	81	5	6e6c5ae39ea880ba809019a7d39f50e4e02007ed
ToppCell	PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_B-B_cell\|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k)	MS4A1 NETO1 TCL1A SETBP1 C16orf74	2.71e-05	193	81	5	c04ac5884be4245b75d211046f04d76ae0cfb998
ToppCell	10x5'-lymph-node_spleen-Lymphocytic_B-Naive_B_cells\|lymph-node_spleen / Manually curated celltypes from each tissue	MS4A1 NETO1 TCL1A C16orf74 KLF4	2.78e-05	194	81	5	20967afbadb3cf80ba9f4d7ebda4e64389252e70
ToppCell	LV-14._Fibroblast_III\|LV / Chamber and Cluster_Paper	NCOR2 SH3PXD2B GLI3 NAV2 SEMA6A	2.78e-05	194	81	5	927c26aea0147f7a4b8fb3f192de4de263f1b978
ToppCell	TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-4\|TCGA-Prostate / Sample_Type by Project: Shred V9	COL8A2 SH3PXD2B RARG GLI3 NAV2	2.85e-05	195	81	5	5562665dd3beb70e2358aa32611a337bef5731c1
ToppCell	Healthy-B_intermediate\|World / disease group, cell group and cell class	MS4A1 NETO1 TCL1A SETBP1 C16orf74	2.85e-05	195	81	5	9de79e0bdd9063ae65e5edb89cc3fe6f9a8173bc
ToppCell	COVID-19-kidney-TAL\|kidney / Disease (COVID-19 only), tissue and cell type	HIVEP3 SEMA6D ESRRB NAV2 PRDM16	2.92e-05	196	81	5	04f5eb206ed3016a737609a3ebac0c1fcabb94ef
ToppCell	Bronchial-NucSeq-Immune_Lymphocytic-B-B_cell-B_naive\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	MS4A1 NETO1 TCL1A SETBP1 C16orf74	2.92e-05	196	81	5	de43dd0697e1daf4d50800957cf0b27b54a7a333
ToppCell	IPF-Epithelial\|IPF / Disease state, Lineage and Cell class	CFAP47 PTPRF TTC29 NAV2 TACC2	2.92e-05	196	81	5	87d9881cfec461a5d89b688a83749b618c519485
ToppCell	COVID-19_Severe-Lymphoid_B\|COVID-19_Severe / Disease group, lineage and cell class	MS4A1 NETO1 TCL1A SETBP1 C16orf74	2.99e-05	197	81	5	25303329b051831cf2ed4df68f3948308e5fbd96
ToppCell	PBMC-Severe-Lymphocyte-B-B_cell\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	MS4A1 NETO1 TCL1A SETBP1 C16orf74	2.99e-05	197	81	5	5c67ed18fb92aec73c79f4db6d80cec777d9ba44
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	FMNL3 HIVEP3 SEMA6A KLF4 CDH13	3.07e-05	198	81	5	07701c73137947ed4a27e225975329235bbb8734
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	FMNL3 HIVEP3 SEMA6A KLF4 CDH13	3.07e-05	198	81	5	31ba87552be97c9b78c9e82f98e96699ccb19824
ToppCell	Primary_Visual_cortex_(V1C)-Neuronal\|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	KIAA1549L SETBP1 PAK1 GABBR2 UNC80	3.07e-05	198	81	5	8ab40fae14fe02e39bc8c8da187a5cd60c787643
ToppCell	Anterior_Cingulate_gyrus_(CgG)-Neuronal\|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	KIAA1549L NETO1 SETBP1 GABBR2 UNC80	3.07e-05	198	81	5	0ff30edfd3c133a42e8cb96e1631a1143215f808
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	CLIP3 MAMLD1 TACC2 UNC80 CDH13	3.14e-05	199	81	5	333056c2abe9724efeab542c0365fcfe4eff8f18
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC-OPC\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	CLIP3 MAMLD1 TACC2 UNC80 CDH13	3.14e-05	199	81	5	e60ecbb8fa7bcd3e2ce7d78f6efb2cfd1fd77698
ToppCell	COVID-19-COVID-19_Mild-Lymphocyte-B\|COVID-19_Mild / Disease, condition lineage and cell class	MS4A1 TCL1A SIPA1L3 SETBP1 C16orf74	3.22e-05	200	81	5	11b51dfca161342d92126e0a83d10864348ba3ef
ToppCell	PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_Arw_fibro_(16)\|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung	RARG NETO1 GABBR2 PRDM16	6.40e-05	118	81	4	e5202fadb3f9d91e56337ddad1666196ec748d87
ToppCell	PND01-03-samps-Mesenchymal-Matrix_fibroblast-FB-2\|PND01-03-samps / Age Group, Lineage, Cell class and subclass	HIVEP3 NETO1 GLI3 NAV2	8.01e-05	125	81	4	6cd741dd1c7ee6b16437cca7c15c99b5c95603fc
ToppCell	COVID-19_Mild-Neu_2\|World / 5 Neutrophil clusters in COVID-19 patients	ABI2 TTC29 PRG4 UNC80	1.24e-04	140	81	4	b1429028c52f84127b894b93b55961badcd5246f
ToppCell	COVID-19-Epithelial_cells-Airway_mucous\|COVID-19 / group, cell type (main and fine annotations)	CFAP47 TTC29 MUC16 TACC2	1.66e-04	151	81	4	8216462e723fec2797387929dde095370947e10a
ToppCell	COVID-19_Severe-B_cell\|COVID-19_Severe / disease group, cell group and cell class	MS4A1 NETO1 TCL1A PDZD4	1.75e-04	153	81	4	701a7d92ee7b22277c8462742a530347cc6f061a
ToppCell	3'_v3-Lung-Lymphocytic_B-Naive_B_cells\|Lung / Manually curated celltypes from each tissue	MS4A1 NETO1 TCL1A C16orf74	1.79e-04	154	81	4	2b7d7f09c75bbc22de1358fc44b8ad5d3f656617
ToppCell	PND28-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_B-B-B_prolif\|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	MS4A1 SIPA1L3 BSN SPIN4	1.93e-04	157	81	4	6730b775308f45a2f3946016bdbb7f8e5b5efe49
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Cortical_Thick_Ascending_Limb_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ZNF597 SEMA6D OTOGL ESRRB	2.02e-04	159	81	4	c186bf05c61fac348cf41973827cced83fafd58a
ToppCell	PBMC-Control-Lymphocyte-B-B_cell-B_naive-B_naive-11\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	MS4A1 NETO1 TCL1A C16orf74	2.07e-04	160	81	4	8396afbc7d919ba190863d50aa0ef8b9942a9866
ToppCell	Adult-Immune-B_cell-D231\|Adult / Lineage, Cell type, age group and donor	MS4A1 NETO1 SETBP1 C16orf74	2.22e-04	163	81	4	4f5821299b265663c7d0352b28285f56e1988841
ToppCell	systemic_lupus_erythematosus-flare-Lymphocytic_B-B_naive-male\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	MS4A1 TCL1A C16orf74 NAV2	2.33e-04	165	81	4	8003fd2aa3f5c9d0e99054af4ad2d79a4a3c4829
ToppCell	10x5'-Lung-Lymphocytic_B-Naive_B_cells\|Lung / Manually curated celltypes from each tissue	MS4A1 NETO1 TCL1A C16orf74	2.33e-04	165	81	4	1776e7db80d7cf6b449fa8635a111705a59231b4
ToppCell	10x5'-Liver-Hematopoietic_progenitors\|Liver / Manually curated celltypes from each tissue	COL8A2 GTSE1 ZNF747 LTBR	2.38e-04	166	81	4	ae967570248cf86ca3ddf55e33bcbb3e4e3684bc
ToppCell	10x5'-Liver-Hematopoietic_progenitors-Cycling_pre-Myeloid-2\|Liver / Manually curated celltypes from each tissue	COL8A2 GTSE1 ZNF747 LTBR	2.38e-04	166	81	4	a176e87aa6eec81d1fb79a028f759182d11b567d
ToppCell	primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2-Exc_L3-4_RORB_SEMA6D\|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	FMNL3 SEMA6D OTOGL TTC29	2.55e-04	169	81	4	319cba07263bf41fcbcbfecd117f91b729394241
ToppCell	Children_(3_yrs)-Immune-B_cell-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	MS4A1 NETO1 SETBP1 C16orf74	2.61e-04	170	81	4	e421f9eedf74baffda1d03707a710ece4b777f29
ToppCell	PBMC-Convalescent-Lymphocyte-B-B_cell-B_naive-B_naive-5\|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	MS4A1 TCL1A ITSN1 C16orf74	2.67e-04	171	81	4	23b3120706bb9c20b9214fe3760c6d7a84f1e749
ToppCell	Primary_Motor_Cortex_(M1)-Non-neuronal-Macroglial-Astro-Astrocyte-Astro_L1_FGFR3_MT1G\|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	CFAP47 SH3PXD2B GLI3 PRDM16	2.73e-04	172	81	4	55fba5ce0ead1114e1a76f67ad68432c6bac90e5
ToppCell	wk_08-11-Mesenchymal-Chondrocyte-intermediate_chondrocyte\|wk_08-11 / Celltypes from embryonic and fetal-stage human lung	LRRC63 COL8A2 RARG SEMA6A	2.73e-04	172	81	4	415d57aa6278b8c12e7a2cf9c3fa5283389fb9b0
ToppCell	PBMC-Mild-Lymphocyte-B-B_cell-B_naive-B_naive-4\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	MS4A1 NETO1 TCL1A C16orf74	2.73e-04	172	81	4	62ed3b70fa1f6c84ea80ff00f60d2562be292e9d
ToppCell	primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2\|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	FMNL3 SEMA6D OTOGL TTC29	2.79e-04	173	81	4	8335b77f730ed43fc348a005566e73a103c6774b
ToppCell	ASK428-Immune-B_cell\|ASK428 / Donor, Lineage and Cell class of Lung cells from Dropseq	MS4A1 MUC16 PRDM16 SPIN4	2.85e-04	174	81	4	b5a7a612a515736cf3489afd0f6ad2054d54526f
ToppCell	Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2-Exc_L3-5_RORB_CD24\|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	FMNL3 SEMA6D OTOGL MAMLD1	2.85e-04	174	81	4	3e29d620b7b4ab1915ddac70ee5a50d09072292b
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	KIAA1549L PIK3R3 AQP7B CDH13	2.85e-04	174	81	4	3d4c05ea5719ca65e85d1f15198453034791087c
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_B-B_cell-B_c04-SOX5-TNFRSF1B\|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k)	MS4A1 NETO1 SETBP1 MEF2A	2.85e-04	174	81	4	ebe6ce173ad12d4a2afa39f8d6185c0e4f97fb1e
ToppCell	ASK428-Immune-B_cell\|Immune / Donor, Lineage and Cell class of Lung cells from Dropseq	MS4A1 MUC16 PRDM16 SPIN4	2.91e-04	175	81	4	e0979e5795a49b4e5c9b88e7fe6b7bda7a413a6c
ToppCell	Adult-Immune-B_cell\|Adult / Lineage, Cell type, age group and donor	MS4A1 NETO1 SETBP1 C16orf74	2.98e-04	176	81	4	4aa00dcde907ad83d3aa4bb10439b7b5c4be1e5d
ToppCell	PND10-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_prolif\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	HIVEP3 NEO1 KIAA1549L SPECC1L	2.98e-04	176	81	4	d30241fb8119834d6e7b59efec3f92fc7a3d1247
ToppCell	PBMC-Convalescent-Lymphocyte-B-B_cell-B_naive-B_activate-7\|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	MS4A1 TCL1A SIPA1L3 PIK3R3	2.98e-04	176	81	4	dde46f06f6fc3f7ba83be91a0ee6231790955e3e
ToppCell	COVID-19-lung-B_cells\|lung / Disease (COVID-19 only), tissue and cell type	MS4A1 NETO1 TCL1A SETBP1	3.04e-04	177	81	4	f54691e5558091c1734ab15153a10bff15ed171e
ToppCell	COVID-19-B_cells-Activated_B_cells\|COVID-19 / group, cell type (main and fine annotations)	MS4A1 NETO1 TCL1A SETBP1	3.04e-04	177	81	4	653bb62a3744d4024ab3186ee01d410ed62832a6
ToppCell	10x5'v1-week_12-13-Lymphocytic_B-B_lineage-naive_B_cell\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	MS4A1 TCL1A SIPA1L3 SETBP1	3.04e-04	177	81	4	325c10674b18727ddd50bf088a9c6f4ef29aa809
ToppCell	PBMC-Convalescent-Lymphocyte-B-B_cell-B_naive-B_naive-8\|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	LMAN2L MS4A1 TCL1A C16orf74	3.04e-04	177	81	4	066e7500e7bdde88a7914f50a4661d8adf6db925
ToppCell	390C-Lymphocytic-B_cell-\|390C / Donor, Lineage, Cell class and subclass (all cells)	MS4A1 NETO1 TCL1A C16orf74	3.11e-04	178	81	4	02cb514096435a4d8c84f0cc12ae627db319621d
ToppCell	PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_B-Plasma_cell-B_c05-MZB1-XBP1\|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k)	GORASP2 ESRRB SETBP1 C16orf74	3.11e-04	178	81	4	6765c6970b1f2b719a20d2afd7471e1c262f3fc4
ToppCell	390C-Lymphocytic-B_cell\|390C / Donor, Lineage, Cell class and subclass (all cells)	MS4A1 NETO1 TCL1A C16orf74	3.11e-04	178	81	4	9af29e341087ba4dd3ef246cdbae6469ea9de15f
ToppCell	TCGA-Liver-Primary_Tumor-Hepatocellular_Carcinoma-Hepatocellular_Carcinoma-1\|TCGA-Liver / Sample_Type by Project: Shred V9	NEO1 RARG KIAA1549L ABI2	3.11e-04	178	81	4	51c59dabf2d7aef1b1964f6f766d5ec07ef90f5a
ToppCell	PBMC-Severe-Lymphocyte-B-B_cell-B_naive-B_naive-11\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	MS4A1 NETO1 TCL1A C16orf74	3.11e-04	178	81	4	5d41fede13c8e64b6fdaf2155f1eb72bcfc32fdb
ToppCell	mild-Lymphocytic-B_cells_2\|mild / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs	MS4A1 NETO1 TCL1A SETBP1	3.11e-04	178	81	4	c6fb21401ad802a57e4e4f5a1723c42779fdb33e
ToppCell	COVID-19-Epithelial_cells-AT1\|COVID-19 / group, cell type (main and fine annotations)	PTPRF NAV2 TACC2 PRDM16	3.17e-04	179	81	4	a0b33bd69ffdfd5d38d80207fb40058a490aa19e
ToppCell	COVID-19-kidney-AQP1+SLC14A1+EC\|COVID-19 / Disease (COVID-19 only), tissue and cell type	KIAA1549L PIK3R3 SETBP1 CDH13	3.17e-04	179	81	4	1ce8d18f63e8dd2d3db41fbeca4601bd3b305fba
Computational	Neighborhood of MAP1B	CEP170 SMAP1 ABI2 GABBR2	1.64e-04	65	46	4	GCM_MAP1B
Computational	Neighborhood of RAP2A	SMAP1 ABI2 GABBR2	4.00e-04	34	46	3	GCM_RAP2A
Drug	irinotecan HCl; Down 200; 100uM; PC3; HT_HG-U133A	NCOA2 ATXN2 GLI3 ITSN1 NAV2 ANKRD17 TACC2	2.39e-06	171	80	7	7535_DN
Drug	ICI 182,780; Up 200; 0.01uM; PC3; HT_HG-U133A	MRS2 SIPA1L3 ZNF747 NCAPH2 SPECC1L GABBR2 KLF4	6.71e-06	200	80	7	1238_UP
Drug	AC1L1JLU	NCOR2 NCOA6 RARG NETO1 PRDM16	3.31e-05	104	80	5	CID000005098
Drug	Oxpl	COL8A2 NETO1 KLF4	3.89e-05	19	80	3	CID000194296
Drug	Trichostatin A, Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A_EA	NCOA2 NCOA6 RARG TENT4A LTBR SREK1	3.91e-05	178	80	6	1112_DN
Drug	Flutamide [13311-84-7]; Down 200; 14.4uM; MCF7; HT_HG-U133A	NCOA2 SIPA1L3 GTSE1 ZNF747 KMT2A SEMA6A	6.31e-05	194	80	6	4361_DN
Drug	Dihydroergotamine tartrate [5989-77-5]; Down 200; 3uM; PC3; HT_HG-U133A	HIVEP3 RARG ITSN1 FOXN3 GABBR2 KLF4	6.49e-05	195	80	6	4502_DN
Drug	Pantothenic acid calcium salt monohydrate [63409-48-3]; Down 200; 8uM; MCF7; HT_HG-U133A	NCOA2 PTPRF GLI3 NCAPH2 MEF2A C2CD2L	6.67e-05	196	80	6	4775_DN
Drug	Fluticasone propionate [80474-14-2]; Down 200; 8uM; MCF7; HT_HG-U133A	HIVEP3 NEO1 SIPA1L3 ZNF747 GABBR2 C2CD2L	6.67e-05	196	80	6	7348_DN
Drug	Sulfadimethoxine [122-11-2]; Up 200; 12.8uM; PC3; HT_HG-U133A	NCOA2 HIVEP3 NCOR2 NCAPH2 FOXN3 GABBR2	6.67e-05	196	80	6	7400_UP
Drug	Deferoxamine mesylate [138-14-7]; Down 200; 6uM; MCF7; HT_HG-U133A	RARG SEMA6D SIPA1L3 ZNF747 KMT2A SEMA6A	6.67e-05	196	80	6	3936_DN
Drug	Amyleine hydrochloride [532-59-2]; Up 200; 14.8uM; PC3; HG-U133A	HIVEP3 ATXN2 TCL1A SIPA1L3 KMT2A NCAPH2	6.86e-05	197	80	6	1909_UP
Drug	Alfaxalone [23930-19-0]; Up 200; 12uM; MCF7; HT_HG-U133A	NCOR2 COL8A2 RARG KIAA1549L SIPA1L3 FOXN3	6.86e-05	197	80	6	6514_UP
Drug	sulindac; Down 200; 100uM; MCF7; HG-U133A	HIVEP3 NCOR2 MRS2 ITSN1 SIPA1L3 KMT2A	6.86e-05	197	80	6	168_DN
Drug	Ticarcillin sodium [4697-14-7]; Down 200; 9.4uM; MCF7; HT_HG-U133A	RARG PTPRF ITSN1 GTSE1 NCAPH2 C2CD2L	6.86e-05	197	80	6	7185_DN
Drug	Deoxycorticosterone [64-85-7]; Down 200; 12.2uM; PC3; HT_HG-U133A	NCOA2 NCOR2 RARG PTPRF ZNF747 GABBR2	6.86e-05	197	80	6	6758_DN
Drug	Piperacetazine [3819-00-9]; Down 200; 9.8uM; MCF7; HT_HG-U133A	NCOA2 PTPRF GLI3 ITSN1 NCAPH2 C2CD2L	7.26e-05	199	80	6	7191_DN
Drug	Laudanosine (R,S) [1699-51-0]; Down 200; 11.2uM; MCF7; HT_HG-U133A	NCOA2 ITSN1 MAMLD1 NCAPH2 FOXN3 C2CD2L	7.26e-05	199	80	6	7030_DN
Drug	Tinidazole [19387-91-8]; Down 200; 16.2uM; MCF7; HT_HG-U133A	HIVEP3 NCOR2 SIPA1L3 NCAPH2 GABBR2 MEF2A	7.46e-05	200	80	6	3896_DN
Disease	biological sex	SEMA6D ATXN2 ITSN1 SETBP1 SEMA6A CDH13	3.38e-05	230	78	6	PATO_0000047
Disease	dedicator of cytokinesis protein 9 measurement	APEH BSN	4.12e-05	4	78	2	EFO_0801521
Disease	electrocardiography	FMNL3 NCOA2 SH3PXD2B SETBP1 NAV2 FOXN3 PRDM16 CDH13	8.00e-05	530	78	8	EFO_0004327
Disease	Neurodevelopmental Disorders	HIVEP3 SETBP1 PAK1 KMT2A	1.10e-04	93	78	4	C1535926
Disease	tumor necrosis factor ligand superfamily member 6, soluble form measurement	APEH BSN	1.44e-04	7	78	2	EFO_0020797
Disease	seasonal gut microbiome measurement	GLI3 NAV2 SPECC1L CDH13	2.26e-04	112	78	4	EFO_0007753
Disease	QRS complex, QRS duration	FMNL3 SETBP1 PRDM16	2.33e-04	45	78	3	EFO_0005054, EFO_0005055
Disease	smoking behavior	SEMA6D PTPRF ATXN2 TTC29 SETBP1 NAV2	2.91e-04	341	78	6	EFO_0004318
Disease	PR domain zinc finger protein 1 measurement	APEH BSN	3.74e-04	11	78	2	EFO_0801904
Disease	cannabis dependence	SEMA6D PTPRF TTC29 DMAC1	4.60e-04	135	78	4	EFO_0007191
Disease	urate measurement, spine bone mineral density	FAM193B NAV2 CDH13	4.94e-04	58	78	3	EFO_0004531, EFO_0007701
Disease	cardiotoxicity, response to anthracycline-based chemotherapy	RARG CDH13	6.15e-04	14	78	2	EFO_0005257, EFO_1001482
Disease	tonsillectomy risk measurement	NCOA2 SH3PXD2B ATXN2 ITSN1 LTBR	6.39e-04	260	78	5	EFO_0007924
Disease	serum gamma-glutamyl transferase measurement	NCOR2 SH3PXD2B SEMA6D SIPA1L3 PIK3R3 NAV2 ZNF747 KMT2A SPECC1L	6.80e-04	914	78	9	EFO_0004532
Disease	response to olanzapine	SPOPL CDH13	7.08e-04	15	78	2	GO_0097333
Disease	hearing loss	TMPRSS9 PIK3R3 NCAPH2	7.54e-04	67	78	3	EFO_0004238
Disease	1-Methylhistidine measurement	NCOA2 OTOGL	9.14e-04	17	78	2	EFO_0021543
Disease	response to bronchodilator, FEV/FEC ratio	NCOA2 NCOR2 SEMA6D MS4A1 TTC29 PAK1 PRDM16 CDH13	9.41e-04	766	78	8	EFO_0004713, GO_0097366
Disease	cup-to-disc ratio measurement	FMNL3 KIAA1549L GLI3 NAV2 KMT2A PRDM16	9.81e-04	430	78	6	EFO_0006939
Disease	Myeloid Leukemia	SETBP1 KMT2A	1.03e-03	18	78	2	C0023470
Disease	Leukemia, Monocytic, Chronic	SETBP1 KMT2A	1.03e-03	18	78	2	C0023466
Disease	attention deficit hyperactivity disorder, Cannabis use	SEMA6D PTPRF	1.03e-03	18	78	2	EFO_0003888, EFO_0007585
Disease	mosaic loss of chromosome Y measurement	TCL1A LTBR PRDM16	1.26e-03	80	78	3	EFO_0007783
Disease	hemoglobin change measurement	KMT2A CDH13	1.54e-03	22	78	2	EFO_0600027
Disease	smoking cessation	SEMA6D PTPRF ATXN2 TTC29 BSN	1.72e-03	325	78	5	EFO_0004319
Disease	osteonecrosis	HIVEP3 DMAC1	1.99e-03	25	78	2	EFO_0004259
Disease	migraine disorder, diastolic blood pressure	NCOR2 PRDM16	1.99e-03	25	78	2	EFO_0006336, MONDO_0005277
Disease	response to TNF antagonist, joint damage measurement	NAV2 GABBR2	1.99e-03	25	78	2	EFO_0004653, EFO_0005413
Disease	Malignant neoplasm of breast	NCOA2 NCOA6 RARG OTOGL SETBP1 PAK1 TACC2 SPOCD1 PDZD4	2.08e-03	1074	78	9	C0006142
Disease	mean arterial pressure	CEP170 HIVEP3 ATXN2 ESRRB PRDM16 MEF2A	2.09e-03	499	78	6	EFO_0006340
Disease	maximal oxygen uptake measurement	ESRRB CDH13	2.15e-03	26	78	2	EFO_0004887
Disease	azoospermia (implicated_via_orthology)	PTPRF ESRRB	2.32e-03	27	78	2	DOID:14227 (implicated_via_orthology)
Disease	stimulant use measurement	NCOA2 CDH13	2.49e-03	28	78	2	EFO_0600076

Protein segments in the cluster

Peptide	Gene	Start	Entry
MGFPSAMLPSPPKQK	CEP170	1506	Q5SW79
KPMKMGYPPSPWTIT	DMAC1	71	Q96GE9
PMKTPPAAAVSPMQR	SPECC1L	871	Q69YQ0
QTPMGCPQPTPKMET	ANKRD17	2161	O75179
NLPIMVTDSGKPPMT	CDH13	656	P55290
PMKGPIAMQSGPKPL	MS4A1	16	P11836
MKMGGLPRTTPPTQK	ABI2	166	Q9NYB9
TEMPTQPGKPLIPPM	NETO1	456	Q8TDF5
RAITLKMEIPGPMPP	RARG	396	P13631
PMSGKPLRMSDLTPV	NOSIP	186	Q9Y314
MMPSVNKSSPRPGGP	MAML1	466	Q92585
TTMTLIPSEMPTPPK	MUC16	11941	Q8WXI7
GPVTMGLPLPMDPKK	NCOR2	1146	Q9Y618
MMLTPPSSPLELMPP	KLF4	391	O43474
PPTPLPNMERMSLKT	GLI3	941	P10071
MNPATTLPGLMPLPA	GORASP2	296	Q9H8Y8
LPKMGSHEPMISPLT	AQP7P3	301	A6NL99
LPKMGSHEPMISPLT	AQP7B	306	A0A075B734
MPKRMSSEGPPRMSP	ATXN2	611	Q99700
DMPRSPGAPTPSPMV	BSN	1516	Q9UPA5
IMALGKLRPPTPPMV	PDZD4	81	Q76G19
EAPLPPMMASLPKKT	MRS2	401	Q9HD23
NMKLPEMTAPLPPLS	LMAN2L	296	Q9H0V9
RFSQLPEMVMGSPPP	KIAA1549L	1626	Q6ZVL6
PSPPPMTVSMKPEGQ	LRRC63	201	Q05C16
VIPPSSKGMMPPLSE	MEF2A	276	Q02078
GLPPMTPKTMPRAVG	GTSE1	521	Q9NYZ3
APLMAGLPTALPMPS	TENT4A	621	Q5XG87
GPSPQRMTPPKQMLS	NCOA6	671	Q14686
LMMTGPKPGPSPLSA	NCOA6	1161	Q14686
KPPAPPMRNTSTMIG	PAK1	11	Q13153
PPKPMTSAVPNGMKD	PIK3R3	41	Q92569
SAPGGLVPSEKPPMM	C2CD2L	261	O14523
HLPSTSMPLLKMPPP	FAM193B	311	Q96PV7
SVPLLLPPGKMPMPE	FMNL3	16	Q8IVF7
MGPVMPPSKKPESSG	FOXN3	1	O00409
MPLPLLPMDLKGEPG	COL8A2	66	P25067
PVPMGSIPVVGMSPT	ITSN1	131	Q15811
EPGPQKMPSMPTTSR	MAMLD1	551	Q13495
PSSPPLSIMGLMPLT	GABBR2	51	O75899
GLSMPGVPKAPPMQV	KMT2A	2491	Q03164
TPPTPTGMMLPRDLG	C16orf74	41	Q96GX8
AMPPPGMPEGDIKAL	ESRRB	226	O95718
MTKTDPAPMAPPPRG	CLIP3	1	Q96DZ5
EGKGMTPLPSSCLPM	CFAP47	2116	Q6ZTR5
TLMPPAKPTVPMFTV	OTOGL	1436	Q3ZCN5
MAPEPAPGRTMVPLV	PTPRF	1	P10586
EPMMLGSPTSPKPGV	NUP35	16	Q8NFH5
KPLMRAPASGTMPMP	RTL9	951	Q8NET4
MMGSLKLLPPPPIMS	SAP25	106	Q8TEE9
PPMLAPVAKSQMPTA	TAF3	246	Q5VWG9
MLHVTPPMSPPDVLK	SQOR	291	Q9Y6N5
IFAPGLPLTPSPMMD	PRDM16	456	Q9HAZ2
LPLTPSPMMDKAKPS	PRDM16	461	Q9HAZ2
PTPMMPPVGVQASIL	NEO1	851	Q92859
GMKSMPGKSPSAPAP	NAV2	591	Q8IVL1
RPSPTTPAMPKMGVR	SIPA1L3	66	O60292
MTSLMPGAGLLPIPT	SREK1	1	Q8WXA9
PKTTPTPRKMTSTMP	PRG4	1046	Q92954
PMTPTQIGPSLLPIM	TCL1A	61	P56279
PGSPPDKTQVPMVVM	APEH	491	P13798
PMEPAGVSPMPGTQK	NCAPH2	201	Q6IBW4
PVNMNPPPLSKMGSL	NCOA2	566	Q15596
IAKMGTPVPRPPQDM	SF3B2	196	Q13435
MVGLKPSDVPPTMAV	UCP3	1	P55916
LPSPVLGMPSVPMFD	UNC80	1681	Q8N2C7
MSREPTPPLPGDMST	SPOPL	1	Q6IQ16
PPGVILPMMPAKHIP	SH3PXD2B	556	A1X283
MSPPTVPPMGVDGVS	SPIN4	1	Q56A73
ACTKDMPPMGSPVIP	SEMA6A	786	Q9H2E6
LSQTPMPAPEMPKTR	SPOCD1	821	Q6ZMY3
MPAPEMPKTRELSPT	SPOCD1	826	Q6ZMY3
MTDPSLGLTVPMAPP	ZNF747	1	Q9BV97
FSEGLMKPPPKPTMP	SAP130	136	Q9H0E3
MRPKPLGTHMLTVPS	HIVEP3	966	Q5T1R4
TKASMPLAPTMAPAP	TMPRSS9	436	Q7Z410
FGPMISNPLPATVMP	SMAP1	246	Q8IYB5
QSPGMSPVPLREPMK	TACC2	196	O95359
KNPLEPLPPEMSGTM	LTBR	211	P36941
MTTLPPLPMTRPKLT	TTC29	1	Q8NA56
MASMPPTPEAQGPIL	ZNF597	1	Q96LX8
SGQPPLKPPSETDMM	USP31	251	Q70CQ4
LKPPSETDMMPEGPS	USP31	256	Q70CQ4
PMGSMSEVPPKVPNR	SEMA6D	911	Q8NFY4
PGGVSKPRKPPMVMT	SETBP1	491	Q9Y6X0